Literature DB >> 26640576

Associations among glycemic excursions, glycated hemoglobin and high-sensitivity C-reactive protein in patients with poorly controlled type 2 diabetes mellitus.

Chun-Hong Shi1, Cong Wang1, Ran Bai1, Xue-Yang Zhang1, Li-Li Men1, Jian-Ling DU1.   

Abstract

The aim of the present study was to explore the associations among glycemic excursions, glycated hemoglobin (HbA1c) and high-sensitivity C-reactive protein (hs-CRP) in patients with poorly controlled type 2 diabetes mellitus (T2DM) using a continuous glucose monitoring system (CGMS). Sixty-three patients with T2DM whose HbA1c levels were >7% wore a CGMS device for 72 h. According to their HbA1c levels, patients were divided into three groups as follows: Group A (HbA1c ≤9.32%), group B (9.32%< HbA1c ≤11.76%) and group C (HbA1c >11.76%). Patients were also divided into two groups according to the mean amplitude of glycemic excursions (MAGE) as follows: Low glycemic excursion group (MAGE, <3.9 mmol/l) and high glycemic excursion group (MAGE, ≥3.9 mmol/l). Clinical data and the hs-CRP levels in different groups were compared. No significant difference was observed in the MAGE among groups A, B and C (P>0.05). The level of hs-CRP was significantly higher in group C compared with that in groups A and B, and in group B compared with that in group A (P<0.05). Multivariate stepwise regression analysis indicated that HbA1c correlated with hs-CRP (P<0.05). MAGE and HbA1c were independent indices for the assessment of glycemic control. In addition, HbA1c had a considerable effect on the serum hs-CRP level.

Entities:  

Keywords:  C-reactive protein; glucose monitoring; glycemic excursion; type 2 diabetes mellitus

Year:  2015        PMID: 26640576      PMCID: PMC4665677          DOI: 10.3892/etm.2015.2730

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  26 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Prevalence of inflammatory markers (high-sensitivity C-reactive protein, nuclear factor-κB, and adiponectin) in Indian patients with type 2 diabetes mellitus with and without macrovascular complications.

Authors:  Durga Prasanna Misra; Sidhartha Das; Pratima Kumari Sahu
Journal:  Metab Syndr Relat Disord       Date:  2012-02-08       Impact factor: 1.894

3.  High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile.

Authors:  Shilpa B Asegaonkar; Amruta Marathe; Mangesh L Tekade; Laxmikant Cherekar; Jayashree Bavikar; Jayashree Bardapurkar; Rote Ajay
Journal:  J Diabetes Complications       Date:  2011-11-04       Impact factor: 2.852

4.  Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.

Authors:  Giovanni Sartore; Nino Cristiano Chilelli; Silvia Burlina; Annunziata Lapolla
Journal:  Acta Diabetol       Date:  2013-02-16       Impact factor: 4.280

5.  Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus.

Authors:  Chih-Min Chang; Ching-Jung Hsieh; Ju-Chun Huang; I-Chin Huang
Journal:  Acta Diabetol       Date:  2012-05-01       Impact factor: 4.280

6.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

7.  Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.

Authors:  Alessandra Di Flaviani; Fabiana Picconi; Paola Di Stefano; Ilaria Giordani; Ilaria Malandrucco; Paola Maggio; Paola Palazzo; Fabrizio Sgreccia; Carlo Peraldo; Fabrizio Farina; Gaetano Frajese; Simona Frontoni
Journal:  Diabetes Care       Date:  2011-05-24       Impact factor: 19.112

8.  Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.

Authors:  David M Nathan; Paula McGee; Michael W Steffes; John M Lachin
Journal:  Diabetes       Date:  2013-08-29       Impact factor: 9.461

9.  Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial.

Authors: 
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

10.  The effects of glucose fluctuation on the severity of coronary artery disease in type 2 diabetes mellitus.

Authors:  Xingguang Zhang; Xiuping Xu; Xiumin Jiao; Jinxiao Wu; Shujing Zhou; Xiaofeng Lv
Journal:  J Diabetes Res       Date:  2013-07-07       Impact factor: 4.011

View more
  2 in total

1.  Increased Glycemic Variability Evaluated by Continuous Glucose Monitoring is Associated with Osteoporosis in Type 2 Diabetic Patients.

Authors:  Rong Huang; Huiying Wang; Ziyang Shen; Tingting Cai; Yunting Zhou; Yuming Wang; Wenqing Xia; Bo Ding; Rengna Yan; Huiqin Li; Jindan Wu; Jianhua Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

2.  Glycemic control with a basal-bolus insulin protocol in hospitalized diabetic patients treated with glucocorticoids: a retrospective cohort study.

Authors:  Elena Chertok Shacham; Hila Kfir; Naama Schwartz; Avraham Ishay
Journal:  BMC Endocr Disord       Date:  2018-10-29       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.